The current work was undertaken to standardize route of administration and the anti-inflammatory activity of a polyherbal formulation. The anti-inflamatory activity of Zuroor-e-Qula was evaluated on carrageenan and histamine induced rat hind paw eina models, upon oral administration and topical plication. The formulation at a dose of 400mg/kg was found to possess significant anti-inflammatory activity on the tested experimental models. The formulation exhibited maximum anti-inflammatory effect, that is 82.58 and 83.57% at the end of 24 h with carrageenan and histamine induced rat paw edema, respectively upon administration. But the effect was negligible, is 32.78% at the end of 6 h with carrageenan induced paw edema, upon local application. In a chronic test, the formulation (400 mg/kg) showed 32.29% reduction in granuloma weight. The histopathological studies of the granuloma tissue were carried out. The effect I produced by the formulation, upon oral administration, was comparable to that of Diclofenac sodium, a prototype of a non-steroidal anti-inflammatory agent.